The new designer drug 5-(2-aminopropyl)indole (5-IT) is an indole derivative with stimulant properties. Its synthesis was first described by Albert Hofmann and Franz Troxler in 1962. We report four deaths associated with 5-IT and a validated high-performance liquid chromatography method for quantitation of the drug. In all four deaths, an autopsy was performed, and femoral venous blood, heart blood, urine and vitreous humor were submitted for toxicological analysis. The blood specimens were subjected to comprehensive testing that included alcohol analysis by headspace gas chromatography (GC-FID), acidic/neutral, basic drug and opiates screening by liquid chromatography -mass spectrometry (LC -MS-MS), and acidic/neutral, basic and acidic drugs screening by HPLC. In Case 1, a 25-year-old male, 3,4-methylenedioxymethamphetamine (MDMA; <0.08 mg/L) and 5-IT ( preserved femoral blood 1.2 mg/L; unpreserved femoral blood 0.8 mg/L; cardiac blood 1.2 mg/L; vitreous 0.8 mg/L and urine >10 mg/L) were detected, and death was attributed to the toxic effects of 5-IT. In Case 2, a 25-year-old female, 3,4-methylenedioxy-N-methylcathinone (methylone, not quantitated), 6-(2-aminopropyl)-benzofuran (6-APB; femoral blood <0.08 mg/L) and 5-IT ( preserved femoral blood 1.0 mg/L; unpreserved femoral blood 0.9 mg/L; cardiac blood 2.6 mg/L; vitreous 1.4 mg/L and urine >10 mg/L) were detected, and death was attributed to the toxic 'cocktail effects' of the drugs. In Case 3, a 22-year-old male with a history of epilepsy, 5-IT (0.5 mg/L femoral blood) and 6-APB (0.2 mg/L femoral blood) were detected, and death was attributed to the toxic effects of the drugs, with the role of epilepsy being indeterminate. In Case 4, a 25-year-old female, 5-IT (0.4 mg/L femoral blood), amphetamine (0.4 mg/L femoral blood), MDMA (1.5 mg/L femoral blood), 4-methyl-N-ethylcathione, 3,4-methylenedioxyamphetamine HCl (MDA), benzylpiperazine and 6-APB were detected, and death was attributed to the 'cocktail effect' of the drugs.
Introduction
Currently, there is a growing market for legal psychoactive substances of abuse that have effects analogous to illicit drugs (1) . These substances, generally marketed as 'research chemicals' or 'legal highs', are mainly synthetic organic products sold online or in specialized shops known as 'head shops' (2) . The use of 'legal highs' has resulted in cases of severe intoxication and fatalities in many countries (2, 3) .
A new addition to the battery of legal substances of abuse is 5-(2-aminopropyl)indole (5-IT), an indole derivative with stimulant effects (4) . Its chemical synthesis was first reported by Albert Hofmann and Franz Troxler (1962) in their patent 'nouveaux de´rive´s de l'indole et leur preparation' (5). The main chemical group that characterizes 5-IT is the indole aromatic compound. Indole has a bicyclic structure, consisting of a benzene ring fused to a pyrrole ring ( Figure 1 ). The other names for 5-IT that can be encountered are 1-(1H-indol-5-yl)propan-2-amine, a-methyl-1H-indole-5-ethanamine and 2-(1H-indol-5-yl)-1-methylethylamine (6) . 5-IT and 5-API are the most common abbreviations for 5-(2-aminopropyl)indole, with 5-IT being the most popular on internet retailer and internet drug forums (6, 7) . 5-IT remains available from some online retailers (8, 9).
To date, no formal study has been carried out on the toxicological and pharmacological properties of 5-IT. Users have reported 5-IT to have stimulant properties similar to those of amphetamine, and the reported toxic effects include pupil dilation, sweating, restlessness, disorientation, anxiety, agitation, tachycardia and high body temperature (6, 10) . In 2012, the Swedish National Laboratory of Forensic Toxicology briefly recorded 14 fatalities where the cause of death was considered to be related to 5-IT. In two of the deaths, only 5-IT was detected and in the remaining cases, 5-IT was found in combination with 'pharmaceuticals' or 'other drugs'. The 5-IT concentration in postmortem blood ranged from 0.7 to 5.2 mg/g in 14 cases, with an additional outlier at 18.6 mg/g.
We describe a validated high-performance liquid chromatography (HPLC) method for the quantitation of 5-IT in biological fluids, and report the circumstances of four deaths, along with autopsy and toxicological findings where 5-IT was detected and quantitated.
Analytical materials and methods
A stock solution of all drugs such as 5-IT [5-(2-aminopropyl)indole hemisuccinate], alpha-methyltriptamine (AMT), amphetamine, 3,4-methylenedioxyamphetamine HCl (MDA), 3,4-methylenedioxymethamphetamine (MDMA), 5-(2-aminopropyl)benzofuran (5-APB) and 6-(2-aminopropyl)benzofuran (6-APB; LGC standards, Teddington, UK) was prepared at a concentration of 1 mg/mL in methanol (Fisher Scientific, Loughborough, UK) and stored at 48C in an amber vial. This stock solution was used to prepare an eightpoint calibration range of 0.078, 0.156, 0.312, 0.625, 1.25, 2.5, 5 and 10 mg/L in blank equine plasma (TCS Biosciences, Buckingham, UK). A separate stock solution of a mixture of all drugs was used to prepare quality control standards of 0.5 and 5.0 mg/L. Calibrator and control samples were prepared prior to each extraction.
The extraction method for the HPLC-diode array detector (DAD) was adapted from a previously published method for basic drugs (11) . In brief, 500 mL of the standard/biological sample was added to a polypropylene test tube, and spiked with 500 mL of an internal standard [8 mg/L of 2-acetaminophenol and 4 mg/L of oxprenolol (Sigma-Aldrich-Fluka, Poole, UK) in 0.2 M Na 2 CO 3 solution at pH 10] and followed by extraction with 5 mL of 1-chlorobutane (Fisher Scientific). After 5 min of rotary mixing, the sample was centrifuged at 5000 rpm for 10 min and the supernatant solvent layer was transferred to a second polypropylene test tube. A back-extraction was carried out with 100 mL of 0.05 M H 2 SO 4 (Sigma-Aldrich-Fluka) . The extract was transferred to a vial for HPLC analysis. The injection volume was 10 mL.
HPLC-DAD analyses were carried out using an UltiMatew 3000 UHPLC Dionex HPLC system (Camberley, UK) consisting of a DAD-3000, WPS-3000SL autosampler, LPG-3400SD lowpressure quaternary pump and TCC-3000SD thermostated column compartment. Data acquisition was by the Chromeleon software (version 6.8) package with the DAD recording spectral data between 200 and 595 nm.
The column used for qualitative analysis was a Phenomenex Synergi Fusion column (150 Â 2.0 mm, 4 mm) protected by a 4 mm Â 3 mm Phenomenex Synergi Fusion guard column (column temperature 258C). HPLC screening used a 4 -70% acetonitrile gradient ramp in 15 min with 70% acetonitrile, a hold for 3 min and a flow of 0.63 mL/min producing a total run time with equilibration of 18 min. The peak detected was compared with a toxicological library that had been updated in-house.
For the new quantitative HPLC-DAD analysis, two-dimensional chromatographic separation (LC Â LC) was carried out using an Agilent Poroshell 120 (100 Â 3.0, 2.7 mm) coupled with a Waters XSelect C18 Column, (2.1 mm Â 150 mm, 3.5 mm) and protected by a Phenomenex KrudKatcher Ultra HPLC in-line filter. The mobile phase used was 25 mM triethylammonium phosphate buffer (Sigma-Aldrich-Fluka) and far UV-grade acetonitrile (Fisher Scientific). The quantitative analysis utilized a multistep gradient with 10% acetonitrile, held for 13.5 min, ramped to 21% acetonitrile, and held for 4.5 min, then decreased back to 10% acetonitrile, and held for 17 min. The total run time was 35 min and the flow rate was 0.6 mL/min, with a column temperature of 358C.
The 5-IT quantification method was validated and the following parameters were assessed: linearity (r 2 ¼ 0.994), limit of detection was 0.007 mg/L, limit of quantification was set at 0.08 mg/L, precision and accuracy. No discernable difference in quantitative results was observed using either 2-acetaminophenol or oxprenolol as the internal standard. All parameters were within acceptable limits (Table I ). The intraday precision of 5-IT quantitation was 10% or better, with an accuracy within 95% of low-and highquality controls. The method showed no interfering peaks at the retention time of 5-IT when investigating the four fatalities, and a calibration model using a linear fit and weighting of 1/Â gave ,5% deviation from the target concentration within the linear range set between 0.08 and 10 mg/L. The use of dual column separation allowed for the baseline separation of amphetamine and MDA from 5-IT (Figure 2 ), which were found to co-elute under isocratic conditions with one C-18 column. The peak separation between the 5-IT and its positional isomer, AMT, was 2.98 min. This proved to be a considerable improvement over the HPLC-DAD method published by Elliott et al. (12) , which had a peak separation of 0.5 min and our HPLC screening method, which required that the UV spectra were overlaid with the 5-IT and AMT standard spectra ( Figure 3 ) in order to distinguish the positional isomers. 5-IT concentrations determined for all the biological fluids in the four fatalities are summarized in Table II .
Qualitative analysis was also carried out using LC -MS-MS with an ABSciex 3200 QTRAP coupled with an Agilent 1200 series HPLC system consisting of a quaternary pump, degasser and an autosampler. None of the cases investigated contained either of the internal standards used in this study. Alcohol analysis was by headspace gas chromatography (GC-FID) with a Perkin Elmer Clarus 500 GC coupled with a TurboMatrix 110 head space sampler. Case reports
Case 1
A 25-year-old male was asthmatic and prescribed salbutamol and seretide. For many years, he had taken recreational drugs, mainly LSD, ecstasy and cannabis, and was also a binge alcohol abuser. Three months prior to his death, he attended hospital following a seizure after taking LSD and cannabis. He died suddenly following taking recreational drugs, and a police investigation reconstructed the events leading up to the death. He had obtained 20-30 'ecstasy' tablets, which were round brown tablets with reflective flecks known as 'Gary Glitters'. He had two associates who had each taken four of these tablets over a period of 3 days previously with no adverse effects. On the afternoon of the first day he consumed alcohol and smoked cannabis beginning at around 3 pm, and by 9 pm had consumed about 1 L of vodka and was heavily intoxicated. At 2 am on the morning of the second day, he and a companion each took one 'ecstasy' tablet and after about 30 min both vomited, which was apparently a normal reaction for them. Each took a further two tablets at intervals and both commented that the tablets were strong. At about 8 am on the second day, the deceased vomited again. He and his companion continued to take tablets at intervals throughout the day, on the evening of the second day and into the morning of the third day. It is estimated that he took between 8 and 10 tablets during that period. On the morning of the third day, each consumed a single larger white pill ('Mitsubishi'), and later that morning each consumed a further two 'Gary Glitters'. Both were now heavily under the influence of drugs. The deceased left the residence with another companion who was not under the influence of drugs at about 3 pm on the third day and traveled by taxi to his home. At this time, he was extremely agitated, complaining of feeling so hot that he removed his jacket and was fidgeting and grabbing the taxi door handle to the extent that the taxi driver threatened to stop and put him out of the taxi. On arrival at his residence, he said that he was fine and did not wish to go to the hospital. However, he soon became unresponsive and although breathing and apparently looking at his companion, was not responding to verbal stimuli. The ambulance services were called, and during the phone call his lips turned blue and his face became gray, after which his breathing became shallow and then stopped entirely. Resuscitation was attempted, but by the time ambulance personnel arrived the pupils were fixed and dilated. Nevertheless, naloxone was administered and further attempts at resuscitation were made, but proved unsuccessful. A later police search of the residence found no recreational drugs and only the antihistamine certirizine.
At autopsy, the body was 92 kg and 195 cm. There were no facial petechiae. The heart (403 g) was entirely normal. The left lung (474 g) was unremarkable, but the right lung (1,232 g) showed extensive confluent hemorrhage involving almost the entire right lower lobe. Histological examination confirmed the autopsy impression of the inhalation of gastric fluid. The stomach contained only 200 mL of watery fluid with no tablet debris. Toxicological analyses revealed the presence of naloxone from the attempted resuscitation by ambulance personnel, together with caffeine and its metabolites, nicotine, certirizine that had been found at the residence, MDMA and 5-IT. The concentration of MDMA was below the level of quantitation (,0.08 mg/L).The results of the quantitative analyses for 5-IT are summarized in Table II . In the absence of any significant natural disease or trauma, death was attributed to the adverse effects of 5-IT. The eye-witness description of the death suggests that the mechanism of death was likely cardiac. The estimated number of tablets taken was between 13 and 15 over 3 days.
Case 2
A 25-year-old female with a long history of migraine for which she was prescribed Sumatriptan 100 mg, to be taken only at the onset of a migraine, died suddenly at her residence after taking recreational drugs. The police investigation reconstructed the events as follows: on Day 1 at about 10 am, together with a companion, she began drinking American whiskey (Jack Daniels) continuing throughout the day so that between them they consumed one and a half bottles. At about 8 pm, each consumed an 'ecstacy' tablet which was circular, brown and speckled. Both continued to drink and they consumed half a bottle of vodka between them. As a result of the effects of alcohol and the drug both were groggy, and falling in and out of sleep. At about 11 am on Day 2 her companion awoke to find that she was lying face down and was no longer breathing. He carried out chest compressions but shortly after, ambulance personnel found that she was already in rigor mortis and no further attempts of resuscitation were made.
At autopsy, 4 days after the death, the body was 160 cm and 46 kg, with a primary pattern of anterior lividity and a secondary pattern of posterior lividity, consistent with her having been found face down some hours after death. There was early putrefactive change with some green discoloration of the anterior abdominal wall. The examination was essentially normal with no significant trauma or natural disease. The heart (239 g) and lungs (492 and 444 g) appeared unremarkable. Toxicology disclosed 5-IT (1.0 mg/L femoral venous blood), 6-APB (,0.08 mg/ L femoral venous blood) and methylone (nonquantified), with death attributed to the 'cocktail effect' of the three drugs, which have similar stimulant properties resulting in a significant overlap in their effects. 6-APB has a similar structure to MDA, but differs in that the 3,4-methylenedioxyphenyl ring system has been replaced with a benzofuran ring. Methylone (3,4-methylenedioxy-N-methylcathinone), also known as 'M1', is a close structural analog of MDMA, differing by the addition of a b-ketone group.
Case 3
A 22-year-old male had a history of a mild form of Von Willebrand's disease requiring no medication, and a diagnosis of epilepsy arising from a single seizure 4 years previously, following which he was prescribed an antiepileptic drug and suffered no further seizures. He died suddenly, having consumed recreational drugs. The reconstruction of events based on police interviews with witnesses was that on Day 1 he played soccer for an amateur team and then went to a public house with a friend, where between about 2 pm and the late evening he consumed more than 20 units of alcohol. Later that evening and into the early hours of the morning he continued drinking at a private residence. At around 3 am on Day 2, he purchased six red tablets and two white tablets that were thought to be ecstasy. He and a companion each took three tablets at 1-h intervals during the morning of Day 2. By 10 am he was sweating and had a vacant look in his eyes. He was helped to drink two glasses of water. By around 3 pm, he was still feeling unwell, his lips were blue and he was fidgeting and slurring his words. He was given a further three glasses of water, but there was no improvement in his condition. An ambulance was called but he was found to be in cardiac arrest and resuscitation attempts were unsuccessful.
At autopsy, he was 174 cm and weighed 65 kg. There were no facial petechial hemorrhages. The autopsy was essentially negative, with a normal heart (314 g), no significant congestion or edema of the lungs (right lung 603 g and left lung 445 g), and no evidence of significant natural disease or trauma.
The urine contained alcohol at a concentration of 66 mg%, but there was no alcohol in the blood or vitreous. Toxicological screening revealed the presence of naloxone from the resuscitation attempts, together with caffeine and its metabolites, 6-APB (0.1 mg/L) and 5-IT (0.4 mg/L). The role of epilepsy in the death, if any, is unclear but the description of his condition prior to death strongly suggests that the death was the direct result of the use of recreational drugs, and that the likely mechanism of death was cardiac.
Case 4
A 25-year-old female with no history of natural disease was a regular user of recreational drugs including cannabis, amphetamine and ecstasy. She died suddenly at a party in a residence, having taken a variety of drugs over a period of time. The police reconstruction of events from eye-witness accounts was that on Day 1 she consumed alcohol and used amphetamine. In the late afternoon of Day 2, she smoked two cannabis joints and took amphetamine before going to a public house and consuming several alcoholic drinks after which she took three 'ecstasy' tablets, which was followed by more alcohol, so that by midnight she appeared drunk. From 3 am on Day 3, she attended a party at a private residence with several people present. More alcohol was consumed and white powder and unknown drugs were consumed by several of the party goers. During Day 3, the deceased appeared to be more and more under the influence of alcohol and drugs and was seen to take a variety of different drugs. She was sweating profusely and later appeared agitated and was mumbling so that she could not be understood. Shortly later, she was found lying on a bed on her back with blue lips, pale face and eyes rolling back but still breathing. Soon afterwards her breathing stopped. Police and ambulance personnel arrived at about 5 pm, but attempts at resuscitation, including the administration of naloxone and adrenaline, were unsuccessful. At autopsy, she was 167 cm and weighed 77 kg. There were no facial petechial hemorrhages. The heart (325 g) was entirely normal. Both lungs were congested and edematous (right lung 708 g and left lung 618 g), and there was copious white foam in the trachea and bronchi. There was no evidence of trauma or natural disease.
Toxicological screening revealed the presence of naloxone from the resuscitation attempts, together with nicotine, cotinine, amphetamine (0.4 mg/L), 4-methyl-N-ethylcathione (0.1 mg/L), MDMA (1.5 mg/L), MDA (0.1 mg/L), BZP, 6-APB and 5-IT (0.3 mg/L). Death was attributed to the combined effects of the various recreational drugs detected, including 5-IT. From the eye-witness accounts, the mechanism of death appears to have been cardiac, which would account for the severe pulmonary edema observed at autopsy.
Discussion
Of the four fatalities, one is undoubtedly attributable directly to the toxic effects of 5-IT, one is attributable to the toxic effects of 5-IT with 6-APB and methylone as possible contributory factors, one is likely due to the toxic effects of 5-IT with 6-APB being a possible contributory factor and epilepsy an indeterminate factor, while the fourth death was the result of a cocktail of similar stimulant drugs of which 5-IT was one. In the four fatalities, the ratio of 5-IT concentration in unpreserved cardiac and femoral blood averaged 1.9 (range 1.3-2.9), raising the possibility that 5-IT may undergo postmortem redistribution, which is emphasized by the substantial cardiac -femoral difference in Case 2 where there was a 4-day delay before autopsy . However, the 5-IT concentration in preserved femoral blood was higher than in unpreserved femoral blood samples for all four cases by an average of 22%, which may be the result of 5-IT instability in blood as a consequence of the fact that indoles are electron-rich and therefore easily oxidized. Consequently, between-case comparisons of 5-IT concentrations in fatalities may prove difficult due to drug instability and drug shifts postmortem. With that caution, the concentrations of 5-IT in fluoride-oxalate preserved femoral venous blood were 1.2 mg/L in the fatality in which it was apparently the sole factor in the death, 1.0 mg/L in the fatality in which it was the principal drug causing death, 0.5 mg/L in the fatality in which it was likely the principal factor in the death and 0.4 mg/L in the death resulting from a cocktail of drugs. The published data from Sweden suggest a much higher concentration of 5-IT in fatalities which ranged in their series from 0.7 to 5.2 mg/g in 14 cases, with an additional outlier at 18.6 mg/g (mg/g in blood approximates mg/L). Our findings suggest that vitreous humor is a potential alternative matrix for the detection of 5-IT, with concentrations of drug in that fluid similar to those in blood. Taken together, the four fatalities suggest that the principal mechanism of death from 5-IT is acute cardiac failure, but the available evidence did not permit a more precise evaluation.
